Fora Capital, LLC Vir Biotechnology, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $97,929 - $153,039	-2,806 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $108,732 - $143,106	2,806 New	2,806 $133 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $14,882 - $46,934	-565 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $14,413 - $24,509	565 New	565 $15,000
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $318,659 - $603,964	-11,268 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $314,264 - $539,286	11,268 New	11,268 $462 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.